key: cord-0259453-f11x70q5
authors: Sharma Timilsina, S.; Durr, N.; Yafia, M.; Sallum, H.; Jolly, P.; Ingber, D. E.
title: Rapid antifouling nanocomposite coating enables highly sensitive multiplexed electrochemical detection of myocardial infarction and concussion markers
date: 2021-06-16
journal: nan
DOI: 10.1101/2021.06.13.21258856
sha: bd982ce00061cb55386479061534594ae594b507
doc_id: 259453
cord_uid: f11x70q5

Here we describe an ultra-fast (< 1 min) method for coating electrochemical (EC) sensors with an anti-fouling nanocomposite layer that can be stored at room temperature for months, which provides unprecedented sensitivity and selectivity for diagnostic applications. We leveraged this method to develop a multiplexed diagnostic platform for detection of biomarkers that could potentially be used to triage patients with myocardial infarction and traumatic brain injury using only 15 microliters of blood. Single-digit pg/mL sensitivity was obtained within minutes for all the biomarkers tested in unprocessed human plasma samples and whole blood, which is much faster and at least 50 times more sensitive than traditional ELISA methods, and the signal was stable enough to be measured after one week of storage. The multiplexed EC sensor platform was validated by analyzing 22 patient samples, which demonstrated excellent correlation with reported clinical values.

robust EC biosensors, which could transform the future of point-of-care (POC) diagnostics given 1 their ability to be mass manufactured at low cost. 5 2

We previously described a highly effective anti-fouling nanocomposite coating composed 3 of denatured bovine serum albumin (BSA) cross-linked to gold nanomaterials or reduced 4 graphene nanoparticles (rGOx) using glutaraldehyde (GA). 12, 17 While this method was simple 5 and greatly suppressed signal noise due to biofouling, it took 24 hours to prepare these 6 surfaces. Here, we report an alternative version of this nanocomposite coating that is composed 7 of BSA cross-linked to pentaamine graphene flakes that can be coated on EC sensors using 8 localized heating in the unprecedented time of less than one minute, which allows for 9 outstanding signal transduction between the gold electrode and the nanocomposite surface. We 10 demonstrate the multiplexing capability and potential clinical value of these coated EC sensors 11 by developing a multiplexed EC diagnostic for multiple blood biomarkers that can be used to 12 triage patients with myocardial infarction (MI) or traumatic brain injury (TBI), and confirming that 13 the values obtained within minutes using this platform with less than one drop of patient blood 14 scale closely with those previously obtained using commercial clinical diagnostics. As this 15 coating method is extremely fast, simple, inexpensive, and scalable, it could enable mass 16 manufacturing of highly sensitive and selective EC sensors for diagnostic as well as industrial 17 applications in the future. 18

To develop an efficient process flow for mass manufacturing, a nanocomposite coating 20 method was developed using on-chip heating to facilitate rapid deposition of our previously 21 described BSA/rGOx composite. 17 Clean gold electrodes were heated at 85 0 C with the 22 nanocomposite material for 30 sec to 5 min, followed by washing in PBS immediately or after 23 cooling down for 10 min. This ultra-rapid cross-linking mechanism results in creation of porous 24 anti-fouling properties even when incubated for up to 9 weeks in either 1% BSA or unprocessed 1 human plasma, with 95.5 and 88% of current densities being maintained, respectively, even 2 after 9 weeks, whereas all signal was lost within 1 day when bare electrodes were exposed to 3 these solutions (Fig. 1h) . Importantly, there also was no significant reduction in current density 4 when the BSA/prGOx/GA-coated sensors were exposed to whole human blood, saliva, or urine 5 for 1h prior to analysis (Fig. 1i) . 6

To better understand the enhanced electrochemical properties of the BSA/prGOx/GA 8 coating, transmission and scanning electron microscopy (TEM and SEM, respectively) were 9

carried out which revealed that this coating is approximately 4.5 nm thick (Supplementary Fig.  10 S2a). Imaging of the BSA/prGOx/GA coated electrodes revealed a heterogenous sponge-like 11 matrix with average pore size of 16.3 nm that occupied 11% of the total surface area, which 12

were not apparent in bare gold or in the BSA/prGOx coating (Fig. 2a) . This more highly porous 13 structure explains the greater surface-diffusion controlled redox reaction observed in the 14 BSA/prGOx/GA coated electrodes (Fig. 1f,g) . The heterogeneity of the surface was further 15 confirmed using atomic force microscopy (AFM) (Fig. 2b,c and Supplementary Fig. S2b) , 16 which depicted a mean roughness of the BSA/prGOx/GA-coated surface (2.92 nm) compared to 17 the already rough bare gold (1.8 nm) (Supplementary Table S1 ). This increased surface 18 roughness of the porous nanocomposite coating results in a greatly increased surface area 19 available for interaction with biomolecules, which significantly influences the activity and 20 concentration of surface-immobilized proteins. 21 21

Evaluation of the chemical morphology of the BSA/prGOx/GA coating was also 22 evaluated using X-ray photoelectron microscopy (XPS) and Time-of-Flight Secondary Ion Mass 23

Spectrometry (TOF-SIMS). In the XPS spectrum, peak of C(1s) peak moved from 284 eV and 24 focuses around 284.7 eV, corresponding to the overlap of C-C, C-H, C=C bonds. C(1s) 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 16, 2021. ; https://doi.org/10.1101/2021.06.13.21258856 doi: medRxiv preprint single-step assay in which sample mixed with soluble detection antibody was immediately 1 added to the capture antibody-coated EC sensor for 30 min, which reduced the total assay time 2 to 36 min. We then optimized the poly-streptavidin-HRP concentration (5 g/mL), and TMB 3 incubation time (2 min) to meet the clinical cut-off range of each biomarkers. Using this 4 optimized assay with antibodies directed against the important MI biomarker, cardiac troponin I 5 (cTnI), we found that current density from the adsorbed TMB was directly proportional to the 6 cTnI concentration (0.01-10 ng/mL) and the limit of detection (LOD) was ~9 pg/mL when spiked 7 in human plasma (Fig. 4b) . In contrast, when a similar assay was run in a traditional ELISA 8 plate, the LOD was ~67 pg/mL (Supplementary Table S2) . 9

Cardiac troponins released into the bloodstream are mainly present in non-covalent 10 ternary complex  cTnI-TC or binary cTnI-C complex  along with some free cTnI. When we 11 attempted to detect the cTnI-TC complex in plasma, we found the LOD of the nanocomposite 12 sensor to be much lower than in the ELISA (3 vs. 24 pg/mL, respectively)( Fig. 4c and  13 Supplementary Table S2), and this is better than the 99th percentile cutoff value (28 pg/mL) in 14 a healthy population used for the clinically approved cardiac troponin assay. 29, 30 Importantly, 15 the nanocomposite coated biosensor also showed ultra-high selectivity with no background 16 signal for commonly found interfering molecules in biological samples, such as uric acid, 17 dopamine, and tryptophan ( Supplementary Fig. S4) . 18

We extended this analysis to detect two other MI biomarkers, B-type natriuretic peptide 19 (BNP) and its N-terminal fragment (NT-proBNP), which show variable levels in circulation 20 according to the clinical condition and timing of measurement and, thus require a rapid and 21 sensitive POC device for clinical use. 31 Our nanocomposite-coated EC sensor displayed a 22 sensitivity for BNP of 26 pg/mL, which is almost 1000-fold better than ELISA (2.8 ng/mL) (Fig.  23   4d) . Likewise, the LOD for NT-proBNP in plasma was 4 pg/mL for the EC sensor compared to 24 65 pg/mL in the ELISA (Fig. 4e) . Importantly, the sensitivity for EC sensor was far better than 25 the clinical cut-off values for BNP (35 pg/mL) and NT-proBNP (125 pg/mL) that have high 1 negative predictive values (0.94-0.98) and can be used for ruling-out heart failure according to 2 clinical guidelines. 32 3

Changes in the expression of Glial fibrillary acidic protein (GFAP) and S100b markers 4 have been shown to correlate with injury magnitude, survivability, and neurologic outcome of 5 TBI. 33 As with the detection of the MI biomarkers, we found that the coated EC sensor was a 6 much more sensitive detector of these TBI biomarkers than the standard ELISA assay (LOD of 7 5 vs. 59 pg/mL for GFAP and 1 vs. 957 pg/mL for S100b, respectively) ( Fig. 4f,g) , and these 8 sensitivities were again better than the current clinical cut-off values (230 pg/mL for GFAP and 9 470 pg/mL for S100b). 33 Moreover, when calibration curves for the cTnI-TC, GFAP, and S100b 10 assays were carried out with unprocessed human whole blood, the LODs were 22, 2, and 13 11 pg/ml, respectively (Supplementary Fig. S5) . Finally, to reduce the overall assay time, enhance 12 analyte transport, and increase binding kinetics, a microfluidic device was developed with 6 13 integrated nanocomposite-coated EC sensors for multiplexed parallel testing of six sensors 14

where LOD of 14 pg/mL and 27 pg/mL was obtained for cTnI-TC and GFAP, respectively, within 15 15 min (Supplementary Fig. S6) . 16

To explore the future utility of this nanocomposite coating method, we compared the 18 rapid (45 sec) coating method with the previously published 24h coating method 12 , using the 19 NT-proBNP assay. We found that the rapid coating is as efficient as the longer method (Fig.  20   5a) . Moreover, the TMB that precipitates on the sensor as a result of ligand detection (Fig. 4a ) 21 is highly stable and produces a similar current density after storage for up to 8 days at room 22 temperature using the GFAP assay (Fig. 5b) . To explore the robustness of the nanocomposite 23 coating solution, it was stored at 4 0 C versus room temperature for up to 20 weeks. The stored 24 sensors were then rapidly coated with nanocomposite solution and a GFAP assay was carried 25 out. These studies revealed that >85% of the current response was maintained when the 1 solution was stored at 4 0 C (Fig. 5c ) or room temperature (Fig. 5d ) compared to the fresh 2 coating. 3

Importantly, the high sensitivity and selectivity of the nanocomposite coated EC sensors 5 made it possible to create a high density multiplexed sensor array and to carry out simultaneous 6 detection of multiple clinically relevant MI and TBI biomarkers (cTnl-TC, S100b, NT-proBNP, 7 and GFAP) by individually functionalizing each sensor's electrode with specific capture 8 antibodies (Fig. 6a) . Using this multiplexed EC sensor device, we were able to specifically 9 detect each ligand individually, and we did not detect any cross-reactivity with capture or 10 detection antibodies (Fig. 6b) . 11

Finally, we tested the multiplexed sensor platform by attempting to detect cTnI-TC and 12 GFAP in 22 patient plasma samples and compared the results to those obtained using the 13 conventional ELISA. The linear regression analysis confirmed that there was an excellent 14 correlation between the EC sensor and the ELISA (r 2 = 0.9848 for cTnI-TC and 0.9819 for 15 GFAP) ( Fig. 6c and Supplementary Fig. S7a ). There also was excellent agreement between 16 the two methods in the lower concentration region (<1 ng/mL) when analyzed using a Bland-17

Altman plot ( Fig. 6d and Supplementary Fig. S7b) . 18 19 Discussion 20

The clinical use of EC sensors has been limited because they suffer from surface fouling 21 when used with biological samples. Antifouling methods have been developed 1, 3, 5, 6 ; however, 22 most have not been validated using clinical samples in complex biological fluids and they 23 require complex manufacturing strategies that are often not consistent with mass manufacturing 24 required for commercial translation. Here, we describe a rapid, versatile, robust, and low-cost 1 method for coating sensors with a highly efficient antifouling nanocomposite coating 2 accomplished using a simple method involving localized heat-induced formation of the coating 3 that occurs in the unprecedented time of less than one minute (at least 3 orders of magnitude 4 faster than methods previously reported in the literature). The nanocomposite provides 5 enhanced antifouling properties while retaining over 95% of electrode conductivity. When 6 fabrication conditions were optimized, gold electrodes retained over 88% of their sensitivity for 7 up to 9 weeks of incubation in unprocessed human plasma, and could be stored at room 8 temperature for at least 20 weeks with 85% current response demonstrating their long-term 9 stability. While this antifouling nanocomposite coating has not been commercialized, and thus, 10 only has been tested under laboratory conditions, we demonstrated its ability to detect clinically 11 relevant biomarkers in patient-derived biological fluids with higher sensitivity and specificity than 12 commercial ELISA assays. Furthermore, the simple and rapid antifouling process used to 13 accomplish this could easily be translated into a reel-to-reel mass manufacturing process and 14 thus, it has enormous potential for commercial development of a marketable device with reliable 15 functioning. 6 16

The porous BSA backbone of the matrix prevents non-specific protein adsorption but 17 allows diffusion of electro-active soluble species. The employment of prGOx, which is highly 18 conductive, accelerates electron transfer and enhances the transduction properties. The rapid 19

antifouling coating method combined with extensive assay development helped to significantly 20 improve the performance of gold electrode based EC sensors, as demonstrated by the 21 increased sensitivity and wide dynamic and linear range of the EC sensors as compared to 22 traditional ELISA assays. These EC sensors with this antifouling coating demonstrate excellent 23

anti-fouling properties shown by the coating in complex biological samples, such as plasma, 24 whole blood, saliva, and urine; they can be multiplexed and still retain high sensitivity and 25 specificity; because they use an EC readout, they can be carried out with minimal training; and 1 they also showed excellent correlation with reported values in clinical samples. Thus, this 2 approach has huge potential for commercial POC diagnostic applications, for example, to 3 combat future crises that may be similar to the current global coronavirus pandemic by detecting 4 viral antigens and host antibodies in the field. The stability of the precipitated TMB for over a 5

week provides additional flexibility that could also enable shipping sensors collected from large 6 populations of patients to a central laboratory when POC detection is not desired. 7

In summary, the development of a simple and rapid method for coating EC sensors with 8 a highly effective antifouling coating using methods that are scalable for mass manufacturing 9 opens up an entirely new path for development of multiplexed EC diagnostics for POC 10 applications. Our proof-of-concept studies demonstrated this for detection of multiple clinical 11 biomarkers for MI and TBI using only a drop of blood, and the results were as good as or better 12 than clinical diagnostics used for this application currently. As this EC sensor system enables 13 rapid diagnosis with only minimal sample handling and users skills, it could be useful for 14 diagnosis at home, as well as in pharmacies, ambulances doctor's offices, and hospitals. While 15 we demonstrated biosensing using detection of labels (TMB), other EC approaches, such as 16 open circuit potential impedance spectroscopy, could be pursued to build a label-free sensing 17 platform in the future. By replacing antibodies with other type of detection ligands (e.g., 18

aptamers, DNA, RNA, CRISPR), even more advanced real-time biosensing could be developed. 19 20

The gold electrode chips custom fabricated using a standard photolithography process 23 and purchased from Telic Company were cleaned as described previously. 17 The 24

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 16, 2021. ; https://doi.org/10.1101/2021.06.13.21258856 doi: medRxiv preprint BSA/prGOx/GA anti-fouling nanocomposite was prepared by mixing 8 mg/mL of prGOx 1 (Millipore Sigma, no. 806579) with 5 mg/mL (IgG-Free, Protease-Free, Bovine Serum Albumin) 2 (Jackson ImmunoResearch, no. 001-000-162) in 10 mM phosphate-buffered saline solution 3 (PBS, pH 7.4) (Sigma Aldrich, USA, no. D8537). A similar method was used to prepare the 4 coating with amine-functionalized reduced graphene oxide (Sigma Aldrich, USA, no. 805432). 5

The solution was sonicated in a tip sonicator for 30 min using 1 s on/off cycles at 50% 6 amplitude, 125 W and 20 kHz (Bransonic, CPX 3800) followed by heating (Labnet, no. D1200) 7

at 105 0 C for 5 min to denature the protein. The resulting opaque black mixture was centrifuged 8 at 16.1 relative centrifugal force for 15 min to remove the excess aggregates. The semi-9 transparent nanocomposite supernatant solution was then mixed with 70% glutaraldehyde 10 (Sigma Aldrich, USA, no. G7776) for crosslinking in the ratio of 70:2. 11

To develop the best coating strategy of the anti-fouling nanocomposite to the gold 13 electrodes of the chips; cleaned and plasma-treated chips were first kept over a hot plate for 2 14 min to let the temperature equilibrate to 85 ºC. 70 μL of anti-fouling nanocomposite as described 15

above was then drop cast to each chip and incubated for 30s-5 minutes. The chips were then 16 washed by dipping in PBS immediately or after cooling down for 10 min followed by washing at 17 400 rpm for 10 min. The chips were then exposed to 1M ethanolamine (Sigma Aldrich, USA, no. 18 E9508) in PBS to quench the unreacted glutaraldehyde groups before electrochemical analysis. 19

For optimization of BSA-glutaraldehyde ratio of the anti-fouling coating, nanocomposite solution 20 was prepared with different concentrations of BSA ranging from 0.5 mg/mL to 10 mg/mL with 3 21 different ratios of BSA & GA (1:70, 2:70, and 4:70). The chips were coated with these solutions 22 for 45s at 85 °C followed by washing and electrochemical analysis. To further develop the 23 nanocomposite that can retain the maximum signal and have the best anti-fouling properties, 24 nanocomposite was prepared with 5 mg/mL BSA with different concentration of prGOx (0.5, 1, 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. ThermoFisher Scientific). The samples were first coated with a thin layer of approximately 6 nm 24 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Cr by sputtering (K755X EM Technologies LTD.). Imaging was carried out by detection of 1 secondary electrons using an in-lens detector at an accelerating voltage of 5 kV. Porosity was 2 calculated from SEM images using the method described previously. 12 

Detection of all the biomarkers was done on the chip using the optimized conditions. 19

Three working electrodes were spotted with a capture antibody concentration of 500 μg/mL 20 diluted in PBS [anti-cTnI (abcam, no. ab243982), anti-cTnI-TC (Advanced ImmunoChemical, no. sample-detection antibody was incubated with agitation at 400 rpm for 30 min followed by 10 washing with PBST (PBS with 0.05 % Tween 20 (Sigma Aldrich, no. P9416)). 5 μg/mL of Poly-11 HRP-Streptavidin (Thermo Fisher Scientific, no. N200) diluted in 0.1% BSA in PBST was added 12 for 5 min. Finally, precipitating 3,3′,5,5′-Tetramethylbenzidine (TMB, Sigma-Aldrich, USA, no. 13 T9455) was added to chips and incubated for 2 min before washing and reading the chips. 14 Finally, measurement was performed in PBST using a potentiostat by a CV with a scan rate of 1 15 V/s between -0.5 and 0.5 V vs on-chip integrated gold quasi reference electrode. Peak height 16 was calculated using Nova 1.11 software for data analysis. Clinical sample validation was 17 performed using the same optimized conditions for cTnI-TC and GFAP. All the experiments ran 18 on the EC-Biosensor had one electrode modified with BSA instead of the capture antibody for 19 the on-chip negative control. No current was observed, signifying that the nanocomposite 20 coating had excellent antifouling properties, and the precipitation of TMB is highly localized 21 without cross-contamination to the neighboring electrodes. 22

For standard ELISA of the biomarkers, 100 μL of 1 μg/mL capture antibody prepared in 24 carbonate-bicarbonate buffer at pH 9.2 was added to Nunc™ MaxiSorp™ ELISA plates 25 (BioLegend, no. 423501) and incubated overnight at 4 ºC. The plates were washed 3 times with 1 200 μL of PBST followed by the addition of 200 μL of 2.5% BSA for 1h. After washing the plates 2 100 μL of different concentrations of the biomarkers in plasma were added and incubated at 3 400 rpm for 1h. After washing the plates biotinylated detection antibody (0.5 μg/mL for cTnI, NT-4 proBNP, cTnITC, and GFAP and 1 μg/mL for BNP and S100b) was added for 1h before 

Specificity of Antigen and Antibody was performed before doing multiplexed detection. 17

For Multiplexed detection, four different capture antibodies (anti-cTnITC, anti-S100b, anti-NT-18 proBNP, and anti-GFAP) was spotted on four different electrodes of the chip at 500 μg/mL. Streptavidin was added for 5 min followed by TMB for 2 min before washing and reading the 1 chips. 2

The microfluidic chip has several inlet and outlet ports and is covered with a special 4 arrangement of cover and adhesive tapes to attach the sensor on top of the microfluidic chip. 5

These tapes also define the flow channel between the sensor and the microfluidic chip 6 ( Supplementary Fig. S6 a,b) . The microfluidic chips were fabricated via 3D printing (Tiger at low pump speeds. The pump system was commanded through an LCD/keypad interface 20 (Adafruit, New York, NY, USA). To perform an assay on the microfluidic platform, the sample 21 mixed with detection antibody (40 µl) was added to inlet wells at the flow rate of 5 µl/min for 8 22

min. An optimized condition of detection antibody as discussed earlier was used. 25 µl of strep-23 HRP was then added at 5 µl/min for 5 min. Finally, 20 µl of TMB was added at 20 µl/min for 1 24 min and incubated under static incubation for 2min. 25

The main data supporting the results in this study are available within the paper and it's 2 Supplementary Information. All raw and processed images/data generated in this work, 3

including the representative images provided in the manuscript, are available from the 4 corresponding authors on reasonable request. 

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. NT-proBNP done on EC-Biosensor with rapid coating (blue) and 24h coating (red). b, Stability of 3 precipitated TMB for detection of GFAP. Bars graph shows the mean current density for GFAP 4 measured just after the assay, day 1 (black dot), day 2 (blue dot), day 4 (red dot), and day 8 5 (orange dot); n=3. Stability of coating solution stored at 4 degrees (c) and room temperature (d) 6

for the assay of GFAP on EC-Biosensor coated with nanocomposite stored for 20 weeks; n=3. 7

Error bars represent the s.d. of the mean. In a, significance was determined by 8 multiple/unpaired t-test (ns P > 0.05; *P < 0.05; **P < 0.01 ***P < 0.001; ****P < 0.0001; all two-9 tailed. In b, Two-way ANOVA was used to observe a significant source of variation, ns P > 0.05. Error bars represent the s.d. of the mean. 19 20 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 16, 2021. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 16, 2021. ; https://doi.org/10.1101/2021.06.13.21258856 doi: medRxiv preprint 1 Fig. 6 2 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 16, 2021. ; https://doi.org/10.1101/2021.06.13.21258856 doi: medRxiv preprint

Recent strategies to minimise fouling in 14 electrochemical detection systems

Label-free impedimetric aptasensor with antifouling surface chemistry: A 16 prostate specific antigen case study

Antifouling strategies for selective in vitro and in vivo sensing

Antifouling Strategies for Electrochemical Biosensing: Mechanisms 21 and Performance toward Point of Care Based Diagnostic Applications

Antifouling strategies in advanced electrochemical sensors and 24 biosensors

Antifouling (bio) 26 materials for electrochemical (bio) sensing

Delayed sensor activation based on transient 29 coatings: Biofouling protection in complex biofluids

PEGylated polyaniline nanofibers: antifouling and 32 conducting biomaterial for electrochemical DNA sensing

A label-free electrochemical DNA 1 biosensor for breast cancer marker BRCA1 based on self-assembled antifouling peptide 2 monolayer

Phytic acid functionalized antifouling conducting 4 polymer hydrogel for electrochemical detection of microRNA

Antifouling zwitterionic coating via electrochemically mediated atom transfer 7 radical polymerization on enzyme-based glucose sensors for long-time stability in 37 C 8 serum

An antifouling coating that enables 10 affinity-based electrochemical biosensing in complex biological fluids

The detection of brucellosis antibody in 13 whole serum based on the low-fouling electrochemical immunosensor fabricated with 14 magnetic Fe3O4@ Au@ PEG@ HA nanoparticles

Mechanism of crosslinking of proteins by glutaraldehyde I: 17 reaction with model compounds

Inorganic electrochemistry: theory, practice and 19 application

Graphene and modified graphene-based polymer nanocomposites-21 a review

Noise Surface Chemistry for Multiplexed Sepsis Biomarker Detection in Whole Blood

Glutaraldehyde: behavior 26 in aqueous solution, reaction with proteins, and application to enzyme crosslinking

Nanoparticle mediated electron 29 transfer across organic layers: from current understanding to applications

A practical beginner's guide to cyclic voltammetry

Synthesis and processing of ELISA polymer substitute: the influence 34 of surface chemistry and morphology on detection sensitivity

Layer uniformity in glucose oxidase immobilization on SiO2 surfaces

Spectroscopic determination of the 39 structure of amorphous nitrogenated carbon films

The optimization of enzyme immobilization at Au-Ti nanotextured 42 platform and its impact onto the response towards glucose in neutral media

Chemical analysis of graphene oxide films after heat and chemical 45 treatments by X-ray photoelectron and Micro-Raman spectroscopy

Characterization of the 48 interaction between graphene and copper substrate by time-of-flight secondary ion mass 49 spectrometry